Evaluation of 1,5-Anhydroglucitol as a Biomarker for Type 2 Diabetes Mellitus in Patients without Overt Nephropathy
1,5-Anhydroglucitol (1,5-AG) is a non-fasting glycemic marker that responds to hyperglycemia excursions. The reduction in serum levels of 1,5-AG is associated with an increase in postprandial glycemia and glycosuria, phenomena that increase the risk and severity of diabetic complications. The object...
Main Authors: | Luiza Cristina Gobor, Waldemar Volanski, Kátia Cristina Boritza, Susan Webber de Souza, Mauren Isfer Anghebem Mauren Isfer Anghebem, Geraldo Picheth, Fabiane Gomes de Moraes Rego |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidade de São Paulo
2021-10-01
|
Series: | Brazilian Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502021000100530&tlng=en |
Similar Items
-
1,5-anhydroglucitol in diabetes: its role in diagnostics, screening, glycemic status assessment, and the prediction of complications
by: V. V. Klimontov, et al.
Published: (2020-08-01) -
1,5-Anhydroglucitol as a Useful Marker for Assessing Short-Term Glycemic Excursions in Type 1 Diabetes
by: Hannah Seok, et al.
Published: (2015-04-01) -
Nonlinear association of 1,5-anhydroglucitol with the prevalence and severity of coronary artery disease in chinese patients undergoing coronary angiography
by: Ruiyue Yang, et al.
Published: (2022-09-01) -
An Efficient Electrochemical Biosensor to Determine 1,5-Anhydroglucitol with Persimmon-Tannin-Reduced Graphene Oxide-PtPd Nanocomposites
by: Guiyin Li, et al.
Published: (2023-03-01) -
Evaluation of serum 1,5-anhydroglucitol levels as hyperglycemic indicator in patients with newly diagnosed type 2 diabetes mellitus
by: Ashok Vanagamudi, et al.
Published: (2022-01-01)